Log in to save to my catalogue

Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer’s...

Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer’s...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2510250454

Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer’s disease

About this item

Full title

Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer’s disease

Publisher

London: Nature Publishing Group UK

Journal title

Molecular psychiatry, 2021-10, Vol.26 (10), p.6074-6082

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Amyloid-β (Aβ) accumulation in the brain is a pivotal event in the pathogenesis of Alzheimer’s disease (AD), and its clearance from the brain is impaired in sporadic AD. Previous studies suggest that approximately half of the Aβ produced in the brain is cleared by transport into the periphery. However, the mechanism and pathophysiological significa...

Alternative Titles

Full title

Physiological clearance of amyloid-beta by the kidney and its therapeutic potential for Alzheimer’s disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2510250454

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2510250454

Other Identifiers

ISSN

1359-4184

E-ISSN

1476-5578

DOI

10.1038/s41380-021-01073-6

How to access this item